Schmidt Ewoud R E, Morello Francesca, Pasterkamp R Jeroen
Department of Neuroscience & Pharmacology, Rudolf Magnus Institute for Neuroscience, University Medical Center Utrecht.
J Vis Exp. 2012 Mar 23(61):3691. doi: 10.3791/3691.
Midbrain dopamine (mdDA) neurons project via the medial forebrain bundle towards several areas in the telencephalon, including the striatum(1). Reciprocally, medium spiny neurons in the striatum that give rise to the striatonigral (direct) pathway innervate the substantia nigra(2). The development of these axon tracts is dependent upon the combinatorial actions of a plethora of axon growth and guidance cues including molecules that are released by neurites or by (intermediate) target regions(3,4). These soluble factors can be studied in vitro by culturing mdDA and/or striatal explants in a collagen matrix which provides a three-dimensional substrate for the axons mimicking the extracellular environment. In addition, the collagen matrix allows for the formation of relatively stable gradients of proteins released by other explants or cells placed in the vicinity (e.g. see references 5 and 6). Here we describe methods for the purification of rat tail collagen, microdissection of dopaminergic and striatal explants, their culture in collagen gels and subsequent immunohistochemical and quantitative analysis. First, the brains of E14.5 mouse embryos are isolated and dopaminergic and striatal explants are microdissected. These explants are then (co)cultured in collagen gels on coverslips for 48 to 72 hours in vitro. Subsequently, axonal projections are visualized using neuronal markers (e.g. tyrosine hydroxylase, DARPP32, or βIII tubulin) and axon growth and attractive or repulsive axon responses are quantified. This neuronal preparation is a useful tool for in vitro studies of the cellular and molecular mechanisms of mesostriatal and striatonigral axon growth and guidance during development. Using this assay, it is also possible to assess other (intermediate) targets for dopaminergic and striatal axons or to test specific molecular cues.
中脑多巴胺(mdDA)神经元通过内侧前脑束投射至端脑的多个区域,包括纹状体(1)。相反,发出纹状体黑质(直接)通路的纹状体中型多棘神经元支配黑质(2)。这些轴突束的发育依赖于大量轴突生长和导向信号的组合作用,这些信号包括由神经突或(中间)靶区域释放的分子(3,4)。这些可溶性因子可通过在胶原基质中培养mdDA和/或纹状体外植体进行体外研究,胶原基质为轴突提供三维底物,模拟细胞外环境。此外,胶原基质允许在附近放置的其他外植体或细胞释放的蛋白质形成相对稳定的梯度(例如,参见参考文献5和6)。在这里,我们描述了大鼠尾胶原的纯化方法、多巴胺能和纹状体外植体的显微切割、它们在胶原凝胶中的培养以及随后的免疫组织化学和定量分析。首先,分离E14.5小鼠胚胎的大脑,显微切割多巴胺能和纹状体外植体。然后将这些外植体在盖玻片上的胶原凝胶中(共)培养48至72小时。随后,使用神经元标记物(例如酪氨酸羟化酶、DARPP32或βIII微管蛋白)观察轴突投射,并对轴突生长以及吸引或排斥性轴突反应进行定量。这种神经元制备方法是研究发育过程中中脑纹状体和纹状体黑质轴突生长及导向的细胞和分子机制的有用体外工具。使用该检测方法,还可以评估多巴胺能和纹状体轴突的其他(中间)靶标或测试特定的分子信号。